Literature DB >> 954364

Plasma enteroglucagon and plasma volume change after gastric surgery.

J P Thomson, S R Bloom.   

Abstract

1. The changes in plasma enteroglucagon concentration and plasma volume were measured after oral glucose in sixteen subjects before and forty-eight subjects after operative treatment for benign duodenal ulceration. Truncal vagotomy with a drainage procedure had been performed in sixteen of the postoperative subjects studied, selective vagotomy with a drainage procedure in seventeen, and partial gastrectomy in fifteen. 2. Patients in whom the glucose produced dumping symptoms had significantly greater enteroglucagon concentrations than those who were symptom-free, which confirms the results of a preliminary study. There was a highly significant correlation between the rate of rise of plasma volume. 3. There was no difference in the rate of rise or in peak plasma enteroglucagon and the rate of fall of plasma volume. 3. There was no difference in the rate of rise or in peak plasma enteroglucagon concentration between the groups of patients who had different operative procedures. This suggests that enteroglucagon release is not under vagal influence. 4. There was no apparent relation between the plasma enteroglucagon concentration and the time-interval between the operation and the time of study, which implies that the exaggerated release of enteroglucagon after operation occurs in response to the altered gastric physiology and that there is minimal adaptive change.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954364     DOI: 10.1042/cs0510177

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  12 in total

1.  Improved glucose tolerance four hours after taking guar with glucose.

Authors:  D J Jenkins; T M Wolever; R Nineham; D L Sarson; S R Bloom; J Ahern; K G Alberti; T D Hockaday
Journal:  Diabetologia       Date:  1980-07       Impact factor: 10.122

2.  Neurotensin.

Authors:  A M Blackburn
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

3.  Plasma levels of glucagon-like polypeptides in patients with esophagoplasty.

Authors:  G Tamburrano; A Lala; M Mauceri; F Tonelli; F Leonetti; D Andreani
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

4.  Pectin and complications after gastric surgery: normalisation of postprandial glucose and endocrine responses.

Authors:  D J Jenkins; S R Bloom; R H Albuquerque; A R Leeds; D L Sarson; G L Metz; K G Alberti
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

5.  Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.

Authors:  R G Long; J R Peters; S R Bloom; M R Brown; W Vale; J E Rivier; D G Grahame-Smith
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

6.  Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

Authors:  F P Alford; S R Bloodm; J D Nabarro
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

7.  Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn.

Authors:  A Lucas; T E Adrian; N Christofides; S R Bloom; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

8.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.

Authors:  J Miholic; C Orskov; J J Holst; J Kotzerke; H J Meyer
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

9.  Gut-hormone profile in totally pancreatectomised patients.

Authors:  H G Dammann; H S Besterman; S R Bloom; H W Schreiber
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

10.  Colonic short chain fatty acids mediate jejunal growth by increasing gastrin.

Authors:  K J Reilly; W L Frankel; A M Bain; J L Rombeau
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.